Overview
The President and Fellows of Harvard College, commonly known as Harvard University, is a private, non-profit Ivy League research university in Cambridge, Massachusetts. It is the oldest institution of higher learning in the United States, founded in 1636. The university's legal corporate name is "The President and Fellows of Harvard College," which also serves as the more powerful of its two governing boards. As of 2024, Harvard reported total revenue of $7.7 billion and had an operating budget of $5.9 billion. The university employs over 20,000 faculty and staff and has a student body of more than 24,000 undergraduate and graduate students.
Products, Services, and Operations
As a major research university, Harvard's primary operations are education and academic research across a vast array of fields, including arts and sciences, engineering, law, medicine, and business. The university grants undergraduate, graduate, and professional degrees. A significant part of its operations involves scientific and technological research that generates new inventions. These intellectual property assets are managed by Harvard's Office of Technology Development (OTD), which is responsible for patenting and commercializing these discoveries. The OTD's mission is to translate new inventions into useful products for society by licensing technologies to existing companies and fostering the creation of startup ventures.
Patent-Litigation Posture
Based on the provided data, Harvard University is an operating company that actively litigates to enforce its patent rights, appearing as a plaintiff. The university's litigation strategy involves partnering with its commercial licensees to assert patents that originate from its research. Through its OTD, Harvard manages a large portfolio of patents and engages in licensing and, when it deems necessary, enforcement litigation to protect its intellectual property.
Notable Cases and Context
The tracked case, 10x Genomics, Inc. et al. v. Element Biosciences, Inc., filed in the District of Delaware, is a recent example of Harvard's patent enforcement activities. In this suit, Harvard joined its exclusive licensee, 10x Genomics, to allege infringement of four patents related to a cell-mapping research platform. This pattern of co-plaintiff litigation with its licensees is common for Harvard. The university has been involved in other high-profile patent disputes alongside 10x Genomics against companies like Vizgen and NanoString Technologies, concerning spatial genomics technology that emerged from Harvard labs. These cases underscore the university's role in developing and defending foundational patents in the life sciences sector.